杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2012/10/24 | 1,667 | 1,685 | 1,662 | 1,675 | -3 | -0.2% | 744,400 |
2012/10/23 | 1,680 | 1,690 | 1,672 | 1,678 | -4 | -0.2% | 770,600 |
2012/10/22 | 1,670 | 1,683 | 1,668 | 1,682 | +4 | +0.2% | 567,100 |
2012/10/19 | 1,670 | 1,680 | 1,665 | 1,678 | +11 | +0.7% | 988,400 |
2012/10/18 | 1,670 | 1,675 | 1,654 | 1,667 | -18 | -1.1% | 2,494,100 |
2012/10/17 | 1,707 | 1,734 | 1,680 | 1,685 | -39 | -2.3% | 1,698,400 |
2012/10/16 | 1,723 | 1,746 | 1,710 | 1,724 | -11 | -0.6% | 550,900 |
2012/10/15 | 1,765 | 1,769 | 1,729 | 1,735 | -45 | -2.5% | 542,900 |
2012/10/12 | 1,790 | 1,810 | 1,777 | 1,780 | -9 | -0.5% | 419,400 |
2012/10/11 | 1,780 | 1,806 | 1,766 | 1,789 | -5 | -0.3% | 323,800 |
2012/10/10 | 1,831 | 1,831 | 1,790 | 1,794 | -37 | -2% | 280,600 |
2012/10/09 | 1,837 | 1,879 | 1,826 | 1,831 | -3 | -0.2% | 350,200 |
2012/10/05 | 1,850 | 1,850 | 1,826 | 1,834 | ±0 | ±0% | 144,200 |
2012/10/04 | 1,806 | 1,852 | 1,806 | 1,834 | +29 | +1.6% | 211,500 |
2012/10/03 | 1,827 | 1,827 | 1,795 | 1,805 | -32 | -1.7% | 386,900 |
2012/10/02 | 1,848 | 1,866 | 1,833 | 1,837 | -11 | -0.6% | 282,400 |
2012/10/01 | 1,851 | 1,861 | 1,834 | 1,848 | -73 | -3.8% | 544,400 |
2012/09/28 | 1,925 | 1,942 | 1,903 | 1,921 | -28 | -1.4% | 251,400 |
2012/09/27 | 1,897 | 1,959 | 1,892 | 1,949 | +52 | +2.7% | 263,000 |
2012/09/26 | 1,836 | 1,907 | 1,836 | 1,897 | +39 | +2.1% | 272,800 |
2012/09/25 | 1,850 | 1,858 | 1,834 | 1,858 | +21 | +1.1% | 154,900 |
2012/09/24 | 1,826 | 1,867 | 1,822 | 1,837 | +16 | +0.9% | 176,000 |
2012/09/21 | 1,780 | 1,828 | 1,770 | 1,821 | +53 | +3% | 158,500 |
2012/09/20 | 1,765 | 1,790 | 1,762 | 1,768 | -17 | -1% | 117,800 |
2012/09/19 | 1,794 | 1,806 | 1,780 | 1,785 | +3 | +0.2% | 92,700 |
2012/09/18 | 1,789 | 1,808 | 1,761 | 1,782 | +26 | +1.5% | 148,600 |
2012/09/14 | 1,792 | 1,792 | 1,752 | 1,756 | -30 | -1.7% | 169,300 |
2012/09/13 | 1,782 | 1,800 | 1,779 | 1,786 | +5 | +0.3% | 69,000 |
2012/09/12 | 1,770 | 1,798 | 1,760 | 1,781 | +17 | +1% | 68,500 |
2012/09/11 | 1,742 | 1,775 | 1,735 | 1,764 | +16 | +0.9% | 161,100 |
2012/09/10 | 1,737 | 1,752 | 1,729 | 1,748 | +13 | +0.7% | 125,000 |
2012/09/07 | 1,772 | 1,774 | 1,728 | 1,735 | -30 | -1.7% | 194,800 |
2012/09/06 | 1,789 | 1,789 | 1,752 | 1,765 | -24 | -1.3% | 98,700 |
2012/09/05 | 1,756 | 1,819 | 1,756 | 1,789 | +11 | +0.6% | 147,300 |
2012/09/04 | 1,788 | 1,789 | 1,751 | 1,778 | -11 | -0.6% | 111,500 |
2012/09/03 | 1,799 | 1,828 | 1,785 | 1,789 | -19 | -1.1% | 116,900 |
2012/08/31 | 1,800 | 1,831 | 1,800 | 1,808 | -8 | -0.4% | 79,200 |
2012/08/30 | 1,839 | 1,839 | 1,801 | 1,816 | -30 | -1.6% | 183,300 |
2012/08/29 | 1,874 | 1,874 | 1,823 | 1,846 | -15 | -0.8% | 165,100 |
2012/08/28 | 1,879 | 1,887 | 1,856 | 1,861 | +7 | +0.4% | 93,500 |
2012/08/27 | 1,874 | 1,888 | 1,853 | 1,854 | -11 | -0.6% | 105,100 |
2012/08/24 | 1,871 | 1,887 | 1,852 | 1,865 | +8 | +0.4% | 124,400 |
2012/08/23 | 1,850 | 1,864 | 1,836 | 1,857 | +15 | +0.8% | 108,000 |
2012/08/22 | 1,848 | 1,851 | 1,833 | 1,842 | +2 | +0.1% | 59,900 |
2012/08/21 | 1,843 | 1,850 | 1,829 | 1,840 | -3 | -0.2% | 134,800 |
2012/08/20 | 1,823 | 1,856 | 1,817 | 1,843 | +21 | +1.2% | 175,800 |
2012/08/17 | 1,825 | 1,828 | 1,797 | 1,822 | -1 | -0.1% | 148,600 |
2012/08/16 | 1,842 | 1,845 | 1,811 | 1,823 | -19 | -1% | 84,500 |
2012/08/15 | 1,859 | 1,859 | 1,828 | 1,842 | -17 | -0.9% | 85,500 |
2012/08/14 | 1,799 | 1,864 | 1,790 | 1,859 | +80 | +4.5% | 247,000 |
3051~
3100
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ジーエヌアイ | 222,700円 | +21.7% | +999.9% | 0.00% | 9.27倍 | 3.07倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 306,500円 | +3.0% | +27.5% | 2.61% | 19.40倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 225,300円 | +0.4% | -8.4% | 2.35% | 28.92倍 | 1.64倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 85,000円 | +22.8% | - | 0.00% | 69.44倍 | 1.12倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム